"Purpose: Clinicopathologic features and biochemical recurrence are sensitive, but not specific, predictors of metastatic disease and lethal prostate cancer. We hypothesize that a genomic expression s
Multivariate model; PSA levels (ng/ml) the number of positive biopsy cores and PSA density (ng/ml) for predicting worse final pathological findings; Statistics: *Chi-Quadrat Pearson; **Fisher test.
ABSTRACT Objective: to develop a predictive model to estimate the probability of prostate cancer prior to biopsy. Methods: from September 2009 to January 2014, 445 men underwent prostate biopsy in a r
ObjectiveThe aim of this study was to develop a predictive model to improve the accuracy of prostate cancer (PCa) detection in patients with prostate specific antigen (PSA) levels ≤20 ng/mL at the ini